ABCL - AbCellera Biologics Inc.
3.45
-0.140 -4.058%
Share volume: 4,246,409
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.59
-0.14
-0.04%
Summary score
39%
Profitability
35%
Dept financing
24%
Liquidity
50%
Performance
44%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-1.96%
Return on sales
-652.21%
Return on invested capital
0%
Total debt ratio
22.94%
Debt ratio change over timeo
0.08%
Current Ratio
8.84%
Quick Ratio
0%
Cash Position Ratio
2.1%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-3.99%
Return on sales
-798.36%
Return on invested capital
0%
Total debt ratio
27.18%
Debt ratio change over timeo
0%
Current Ratio
10.52%
Quick Ratio
0%
Cash Position Ratio
1.77%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-1.87%
Return on sales
-63.72%
Return on invested capital
0%
Total debt ratio
28.74%
Debt ratio change over time
0%
Current Ratio
11.32%
Quick Ratio
0%
Cash Position Ratio
2%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-35.36%
Return on sales
217.78%
Return on invested capital
0%
Total debt ratio
8.07%
Debt ratio change over time
0.08%
Current Ratio
23.61%
Quick Ratio
0%
Cash Position Ratio
10.44%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABCL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -1.96% | 4.74% | 3.19% | 1.73% |
| Return on sales | -652.21% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 22.94% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0.08% | -20.57% | -85.61% | 17.33% |
| Dept financing | 6% | 21% | 16% | 50% |
| Current Ratio | 10.52% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.77% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 30% | 33% | 24% |
| Short-term ratios | ABCL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -3.99% | 6.06% | 4.18% | 1.7% |
| Return on sales | -798.36% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 27.18% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 20% | 15% | 25% |
| Current Ratio | 10.52% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.77% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 31% | 28% | 17% |